Atlas Trials

Relapse Remitting Multiple Sclerosis

9 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Relapse Remitting Multiple Sclerosis

RecordFirmDate
Study to Assess the Effect of Ofatumumab in Treatment Naïve, Very Early RRMS Patients Benchmarked Against Healthy Controls. (NCT05084638)Novartis Pharmaceuticals2022-01-25
Immunoregulatory Effect of Microparticle Delivered STING Agonist in the Control of Experimental Autoimmune Encephalomyelitis (EAE) and Multiple Sclerosis (MS) (NCT05705986)Thomas Jefferson University2021-02-26
Deficient T Regulatory Cell (Treg) Function in Patients With Relapsing Remitting Multiple Sclerosis (NCT04857489)Thomas Jefferson University2020-06-01
A Study to Assess the Effect of a Single Infusion of VAY736 on Disease Activity in Patients With Relapsing-remitting Multiple Sclerosis (NCT02038049)Novartis Pharmaceuticals2013-12-20
Effect of Fingolimod on the Cardiac Autonomic Regulation in Patients With Multiple Sclerosis (NCT01704183)Kuopio University Hospital2012-12-01
Safety and Efficacy Study of Copaxone Administered in Combination With N-Acetylcysteine (NCT00203099)Teva Branded Pharmaceutical Products R&D, Inc.2004-12-01
Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline (NCT00203112)Teva Branded Pharmaceutical Products R&D, Inc.2004-06-01
A Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg, the Currently Approved Dose (NCT00202982)Teva Branded Pharmaceutical Products R&D, Inc.2003-08-01

Track Relapse Remitting Multiple Sclerosis automatically

Every clearance here is in the API, with alerts when new ones post.